
USA - NASDAQ:CERN - US1567821046 - Common Stock
The current stock price of CERN is 94.92 null. In the past month the price increased by 1.33%. In the past year, price increased by 16.8%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.7 | 48.48B | ||
| DOCS | DOXIMITY INC-CLASS A | 32.04 | 9.84B | ||
| WAY | WAYSTAR HOLDING CORP | 26.95 | 6.89B | ||
| HTFL | HEARTFLOW INC | N/A | 2.82B | ||
| CERT | CERTARA INC | 17.24 | 1.38B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.33B | ||
| PHR | PHREESIA INC | N/A | 1.36B | ||
| SDGR | SCHRODINGER INC | N/A | 1.35B | ||
| CTEV | CLARITEV CORP | N/A | 952.62M | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.74 | 1.06B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 601 | 1.02B |
Cerner Corp. designs, develops, markets, installs, hosts and supports health care information technology, health care devices, hardware and content solutions for health care organizations and consumers. The company is headquartered in North Kansas City, Missouri and currently employs 25,150 full-time employees. The firm offers intelligent solutions and technology-enabled services that support the clinical, financial and operational needs of organizations. The firm's segments include Domestic segment includes revenue contributions and expenditures associated with business activity in the United States, and the International segment includes revenue contributions and expenditures linked to business activity outside the United States, primarily from Australia, Canada, Europe, and the Middle East. The company also offers integrated clinical and financial systems to help manage day-to-day revenue functions to support clinical, financial and operational needs. Cerner's solutions are offered on the unified Cerner Millennium architecture and on the HealtheIntent cloud-based platform. Cerner also has an electronic health record (EHR) agnostic platform, CareAware, which facilitates connectivity of healthcare devices to EHRs.
CERNER CORP
2800 Rockcreek Pkwy, W0162, Attn: Cerner Legal
North Kansas City MISSOURI 64117 US
CEO: Brent Shafer
Employees: 25150
Phone: 18162211024.0
Cerner Corp. designs, develops, markets, installs, hosts and supports health care information technology, health care devices, hardware and content solutions for health care organizations and consumers. The company is headquartered in North Kansas City, Missouri and currently employs 25,150 full-time employees. The firm offers intelligent solutions and technology-enabled services that support the clinical, financial and operational needs of organizations. The firm's segments include Domestic segment includes revenue contributions and expenditures associated with business activity in the United States, and the International segment includes revenue contributions and expenditures linked to business activity outside the United States, primarily from Australia, Canada, Europe, and the Middle East. The company also offers integrated clinical and financial systems to help manage day-to-day revenue functions to support clinical, financial and operational needs. Cerner's solutions are offered on the unified Cerner Millennium architecture and on the HealtheIntent cloud-based platform. Cerner also has an electronic health record (EHR) agnostic platform, CareAware, which facilitates connectivity of healthcare devices to EHRs.
The current stock price of CERN is 94.92 null. The price decreased by -0.05% in the last trading session.
CERNER CORP (CERN) has a dividend yield of 1.14%. The yearly dividend amount is currently 0.93.
CERN has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for CERNER CORP (CERN) is 27.28. This is based on the reported non-GAAP earnings per share of 3.48 and the current share price of 94.92 null.
The next ex-dividend date for CERNER CORP (CERN) is March 25, 2022.
The Revenue of CERNER CORP (CERN) is expected to grow by 3.95% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a technical rating of 7 / 10 to CERN. When comparing the yearly performance of all stocks, CERN is one of the better performing stocks in the market, outperforming 93.89% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to CERN. CERN scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months CERN reported a non-GAAP Earnings per Share(EPS) of 3.48. The EPS increased by 20.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.15% | ||
| ROA | 7.99% | ||
| ROE | 15.08% | ||
| Debt/Equity | 0.41 |
21 analysts have analysed CERN and the average price target is 96.34 null. This implies a price increase of 1.5% is expected in the next year compared to the current price of 94.92.
For the next year, analysts expect an EPS growth of 12.81% and a revenue growth 3.95% for CERN